1. Home
  2. BFRG vs PFSA Comparison

BFRG vs PFSA Comparison

Compare BFRG & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

HOLD

Current Price

$1.12

Market Cap

13.1M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.12

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFRG
PFSA
Founded
2017
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
11.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BFRG
PFSA
Price
$1.12
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
68.3K
10.1M
Earning Date
11-14-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,670.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
122.22
52 Week Low
$0.80
$0.10
52 Week High
$4.84
$12.76

Technical Indicators

Market Signals
Indicator
BFRG
PFSA
Relative Strength Index (RSI) 53.78 N/A
Support Level $0.98 N/A
Resistance Level $1.21 N/A
Average True Range (ATR) 0.08 0.00
MACD 0.01 0.00
Stochastic Oscillator 63.71 0.00

Price Performance

Historical Comparison
BFRG
PFSA

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: